Azurebio Overview

  • Founded
  • 2007
  • Status
  • Out of Business
  • Employees
  • 7
  • Latest Deal Type
  • Out of Business

Azurebio General Information


Provider of medical devices intended to facilitate human health by incorporating discoveries in biomaterials into clinical practice. The company's medical devices offer drug formulation services in development of lyophilisates and liquid formulations of small molecules, peptides, proteins and vaccines, enabling patients to get restoration therapies for bone defects in periodontology, implantology and maxillofacial surgery.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Other Devices and Supplies
Primary Office
  • C Ronda de Poniente 16
  • Bajo L, Tres Cantos
  • 28760 Madrid
  • Spain
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Azurebio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Nov-2016 00.000 Completed Out of Business
2. Early Stage VC 10-May-2011 00.000 00.000 Completed Generating Revenue
1. Debt - General 01-May-2011 $507K $507K Completed Generating Revenue
To view Azurebio’s complete valuation and funding history, request access »

Azurebio Executive Team (2)

Name Title Board Seat Contact Info
Arcadio Garcia Castro Ph.D Co-Founder, Director & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Azurebio Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial